About recombina nt human epidermal
Recombinant human epidermal growth factor
Used for
- Promotes healing of deep, complicated diabetic foot ulcers.
Usual adult dose
Injected into the ulcer by a trained clinician, commonly three times weekly for up to eight weeks.
Common side effects
- Injection-site pain or burning
- Shivering
- Headache
- Nausea
Important warnings
- For intralesional use only; administration requires trained healthcare professionals.
- Assess and treat infection, poor circulation, and other causes affecting wound healing.
- Avoid use with known allergy to the product or its ingredients.
- May increase tissue growth; clinicians should assess unusual or suspicious wounds.
Pregnancy
Safety is not established; human pregnancy data are limited.
Breastfeeding
Safety is not established; information on use during breastfeeding is limited.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.